A phase I/II study of CO 1686 in patients with non-small cell lung cancer and EGFR mutation in Asia
Latest Information Update: 30 Mar 2012
At a glance
- Drugs Rociletinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 30 Mar 2012 New trial record